Key Laboratory of Pediatric Hematology and Oncology Ministry of Health, Department of Hematology & Oncology, Pediatric Translational Medicine Institute, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
Cell Death Dis. 2019 Mar 20;10(4):271. doi: 10.1038/s41419-019-1502-8.
Mechanisms underlying the generation of induced pluripotent stem cells (iPSC) and keeping iPSC stability remain to be further defined. Accumulated evidences showed that iPSC reprogramming may be controlled by the cell-division-rate-dependent model. Here we reported effects of absence of mouse p27 or p18 on iPSC generation efficiency and genomic stability. Expression levels of cyclin-dependent kinases inhibitors (CDKIs), p21, p27, and p18 decreased during iPSC reprogramming. Like p21 loss, p27 or p18 deficiency significantly promoted efficiency of iPSC generation, whereas ectopic expression of p27, p18, or treatment with CDK2 or CDK4 inhibitors repressed the reprogramming rate, suggesting that CDKIs-regulated iPSC reprogramming is directly related with their functions as CDK inhibitors. However, unlike p21 deletion, absence of p27 or p18 did not increase DNA damage or chromosomal aberrations during iPSC reprogramming and at iPSC stage. Our data not only support that cell cycle regulation is critical for iPSC reprogramming, but also reveal the distinction of CDKIs in somatic cell reprogramming.
诱导多能干细胞(iPSC)生成和维持 iPSC 稳定性的机制仍有待进一步明确。大量证据表明,iPSC 重编程可能受细胞分裂率依赖性模型控制。在这里,我们报告了缺失小鼠 p27 或 p18 对 iPSC 生成效率和基因组稳定性的影响。细胞周期蛋白依赖性激酶抑制剂(CDKIs)、p21、p27 和 p18 的表达水平在 iPSC 重编程过程中降低。与 p21 缺失一样,p27 或 p18 缺失显著提高了 iPSC 生成效率,而 p27、p18 的异位表达或用 CDK2 或 CDK4 抑制剂处理则抑制了重编程率,表明 CDKIs 调控的 iPSC 重编程与其作为 CDK 抑制剂的功能直接相关。然而,与 p21 缺失不同,缺失 p27 或 p18 并不会在 iPSC 重编程过程中和 iPSC 阶段增加 DNA 损伤或染色体异常。我们的数据不仅支持细胞周期调控对 iPSC 重编程至关重要,还揭示了 CDKIs 在体细胞重编程中的区别。